Literature DB >> 30037437

Rapid Fire: Infectious Disease Emergencies in Patients with Cancer.

Stephanie Charshafian1, Stephen Y Liang2.   

Abstract

Patients with cancer can be immunocompromised because of their underlying malignancy as well as the medical therapies with which they are treated. Infections frequently present atypically and can be challenging to diagnose. The spectrum of infectious diseases encountered in patients receiving chemotherapy, hematopoietic stem cell transplant, and immunotherapy is broad depending on the depth of immunosuppression. Early recognition of infectious processes followed by appropriate diagnostic testing, imaging, and empiric antibiotic therapy in the emergency department are critical to providing optimal care and improving survival in this complex patient population.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Cytokine release syndrome; Emergency department; Hematopoietic stem cell transplant; Infections; Neutropenic fever

Mesh:

Substances:

Year:  2018        PMID: 30037437      PMCID: PMC6060634          DOI: 10.1016/j.emc.2018.04.001

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  55 in total

Review 1.  Neutropenic enterocolitis.

Authors:  Brant W Ullery; Fredric M Pieracci; John R M Rodney; Philip S Barie
Journal:  Surg Infect (Larchmt)       Date:  2009-06       Impact factor: 2.150

2.  Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia.

Authors:  Regis G Rosa; Luciano Z Goldani
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

3.  Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.

Authors:  A S Monto; D M Fleming; D Henry; R de Groot; M Makela; T Klein; M Elliott; O N Keene; C Y Man
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

4.  Validation of MASCC Score for Risk Stratification in Patients of Hematological Disorders with Febrile Neutropenia.

Authors:  M Taj; M Nadeem; S Maqsood; T Shah; T Farzana; T S Shamsi
Journal:  Indian J Hematol Blood Transfus       Date:  2016-10-01       Impact factor: 0.900

Review 5.  How to approach neutropenia.

Authors:  Laurence A Boxer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

6.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

7.  Microbiological data for patients with febrile neutropenia.

Authors:  Akihisa Kanamaru; Youichi Tatsumi
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

8.  Management of fever in neutropenic patients with different risks of complications.

Authors:  Jean Klastersky
Journal:  Clin Infect Dis       Date:  2004-07-15       Impact factor: 9.079

9.  Current concepts in the diagnosis and management of cytokine release syndrome.

Authors:  Daniel W Lee; Rebecca Gardner; David L Porter; Chrystal U Louis; Nabil Ahmed; Michael Jensen; Stephan A Grupp; Crystal L Mackall
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

Review 10.  Infectious complications of stem cell transplantation.

Authors:  Charulata Ramaprasad; Kenneth J Pursell
Journal:  Cancer Treat Res       Date:  2014
View more
  2 in total

1.  Precision immunization: a new trend in human vaccination.

Authors:  Siyue Jia; Jingxin Li; Yuanbao Liu; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

2.  Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes.

Authors:  Xiaoqiong He; Qian Yao; Dan Fan; Yutong You; Wenjing Lian; Zhangping Zhou; Ling Duan
Journal:  Discov Oncol       Date:  2022-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.